In addition, felodipine treatment decreased NLRP3 mRNA levels in the cortex and hippocampus region of Tau Tg PS19 mice (Fig. 1E), suggesting that felodipine treatment may downregulate tauopathy-associated neuroinflammatory responses by inhibiting NLRP3 expression. The gene discussed is MAPT; the disease is tauopathy.